4 days; P < .001) and a lower risk of recurrent
bleeding at 12 months (0% vs 23%, P < .001). Others
have similarly reported excellent control of bleeding
from smaller veins (<1 mm) with sclerotherapy, while
bleeding from larger veins was successfully controlled
with high ligation, stripping, and phlebectomy. Recurrent bleeding was noted in only 1 of 14 patients (